Back to User profile » Dr Robert Andtbacka

Paper published by Dr Robert Andtbacka:


Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial

Harrington KJ, Andtbacka RHI, Collichio F, Downey G, Chen L, Szabo Z, Kaufman HL

OncoTargets and Therapy 2016, 9:7081-7093

Published Date: 16 November 2016